4.6 Letter

Extending use of levonorgestrel 52 mg intrauterine device to 8 years

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Obstetrics & Gynecology

Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use

Mitchell D. Creinin et al.

Summary: This study aimed to evaluate the efficacy and safety of the levonorgestrel 52 mg intrauterine system during years 7 and 8 of use. The results showed that the system is highly effective and safe over an 8-year period of use, with low pregnancy rates and high user satisfaction.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Article Obstetrics & Gynecology

Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial

Jeffrey T. Jensen et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Editorial Material Obstetrics & Gynecology

Extending use of 52-mg levonorgestrel intrauterine systems to 8 years: bridging phases of life

Alisa B. Goldberg

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)